Tags

Type your tag names separated by a space and hit enter

ACP Journal Club. Review: oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints.
Ann Intern Med 2011; 155(4):JC2-4AIM

Authors+Show Affiliations

Universidad Peruana Cayetano Heredia, Lima, Peru.No affiliation info availableNo affiliation info available

Pub Type(s)

Comment
Journal Article

Language

eng

PubMed ID

21844537

Citation

Domecq, Juan Pablo, et al. "ACP Journal Club. Review: Oral Drugs for Type 2 Diabetes, Alone or in Combination, Have Different Relative Benefits and Harms for Surrogate Endpoints." Annals of Internal Medicine, vol. 155, no. 4, 2011, pp. JC2-4.
Domecq JP, Prutsky G, Montori VM. ACP Journal Club. Review: oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints. Ann Intern Med. 2011;155(4):JC2-4.
Domecq, J. P., Prutsky, G., & Montori, V. M. (2011). ACP Journal Club. Review: oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints. Annals of Internal Medicine, 155(4), pp. JC2-4. doi:10.7326/0003-4819-155-4-201108160-02004.
Domecq JP, Prutsky G, Montori VM. ACP Journal Club. Review: Oral Drugs for Type 2 Diabetes, Alone or in Combination, Have Different Relative Benefits and Harms for Surrogate Endpoints. Ann Intern Med. 2011 Aug 16;155(4):JC2-4. PubMed PMID: 21844537.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - ACP Journal Club. Review: oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints. AU - Domecq,Juan Pablo, AU - Prutsky,Gabriela, AU - Montori,Victor M, PY - 2011/8/17/entrez PY - 2011/8/17/pubmed PY - 2011/8/17/medline SP - JC2 EP - 4 JF - Annals of internal medicine JO - Ann. Intern. Med. VL - 155 IS - 4 SN - 1539-3704 UR - https://www.unboundmedicine.com/medline/citation/21844537/ACP_Journal_Club__Review:_oral_drugs_for_type_2_diabetes_alone_or_in_combination_have_different_relative_benefits_and_harms_for_surrogate_endpoints_ L2 - https://www.annals.org/aim/fullarticle/doi/10.7326/0003-4819-155-4-201108160-02004 DB - PRIME DP - Unbound Medicine ER -